You want your clinical trial to remain compliant, but the Food & Drug Administration’s (FDA) ever-evolving racial and ethnic diversity recommendations are hard to pin down. When you add in the endless noise from the media and differing industry opinions, things only get more complicated. What does the FDA really say about diversity in clinical trials? What do you need to do now to make sure you remain compliant?
Our white paper, “Racial and Ethnic Diversity in FDA Regulated Clinical Trials,” answers these questions and more, giving you the insight you need to successfully run a compliant, diverse study.
Download it now to learn:
- A brief history of the FDA and its diversity guidances
- What happened at the most recent public workshop
- Steps sponsors should take now to meet the FDA’s diversity requirements
When you need to advance your MedTech, It Takes Avania.